Skip to main content

Trulieve Cannabis Corp.

For the period ended Jun 30, 2026. Filed Aug 7, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 7, 2026

TRLV$11.09+0.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(in thousands)

Six Months EndedJune 30,
20262025
Cash flows from operating activities
Net loss$(403,779)$(49,870)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization55,46658,755
Depreciation included in cost of goods sold27,41927,577
Loss on Deconsolidation Transaction403,333—
Equity in net loss of Harvest3,289—
Impairment and disposal of long-lived assets, net of recoveries1,707(175)
Gain from disposal of discontinued operations(7)—
Share-based compensation11,05010,705
Deferred income taxes(19,059)(9,919)
Other non-cash changes6,73612,258
Changes in operating assets and liabilities:
Inventories6,000(10,093)
Accounts receivable(2,712)(3,368)
Other assets(30,735)(998)
Accounts payable and accrued liabilities(3,394)(11,813)
Income tax receivable / payable1,1032,705
Uncertain tax position liabilities60,955114,445
Other liabilities(8,525)(8,716)
Proceeds received from insurance for operating expenses—5,731
Net cash provided by operating activities108,847137,224
Cash flows from investing activities
Capital expenditures(34,495)(36,808)
Maturities of short-term investments—60,000
Cash disposed in Deconsolidation Transaction(58,395)—
Other proceeds4,84111,399
Other purchases and payments—(205)
Net cash (used in) provided by investing activities(88,049)34,386
Cash flows from financing activities
Proceeds from long-term borrowings60,742—
Payments on long-term borrowings(3,741)(5,455)
Payments for debt issuance costs(1,287)—
Other payments and distributions(5,376)(4,583)
Payments for taxes related to net share settlement of equity awards(1,251)(295)
Net cash provided by (used in) financing activities49,087(10,333)
Net increase in cash and cash equivalents, and restricted cash69,885161,277
Cash, cash equivalents, and restricted cash, beginning of period255,535239,710
Cash, cash equivalents, and restricted cash, end of period$325,420$400,987
Supplemental disclosure of cash flow information
Cash paid during the period for
Interest$26,928$32,729
Income taxes paid, net of refunds964394
Noncash investing and financing activities
ASC 842 lease additions - operating and finance leases$18,964$12,750
Purchases of property and equipment in accounts payable and accrued liabilities4,1231,452
Operating license intangible placed into service, transfer from other assets—6,500

The condensed consolidated statements of cash flows include continuing operations and discontinued operations for the periods presented.

The following table summarizes the cash, cash equivalent, and restricted cash balances for each of the periods presented:

Six Months EndedJune 30,
20262025
Beginning of period:
Cash and cash equivalents (1)$255,535$238,803
Restricted cash—907
Cash, cash equivalents, and restricted cash$255,535$239,710
End of period:
Cash and cash equivalents (1)$325,420$392,580
Restricted cash—8,407
Cash, cash equivalents, and restricted cash$325,420$400,987

(1) Excludes discontinued operations, which did not generate cash flows in any period presented.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.